Nuvectis Pharma Inc
NASDAQ:NVCT

Watchlist Manager
Nuvectis Pharma Inc Logo
Nuvectis Pharma Inc
NASDAQ:NVCT
Watchlist
Price: 8.51 USD 12.72% Market Closed
Market Cap: 217.9m USD

Net Margin
Nuvectis Pharma Inc

0%
Current
0%
Average
-6.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-27.8m
/
Revenue
0

Net Margin Across Competitors

No Stocks Found

Nuvectis Pharma Inc
Glance View

Market Cap
218.2m USD
Industry
Biotechnology

Nuvectis Pharma, Inc. is a preclinical stage biopharmaceutical company. The company is headquartered in Fort Lee, New Jersey and currently employs 8 full-time employees. The company went IPO on 2022-02-04. The firm focuses on the development of precision medicines for the treatment of unmet medical needs in oncology. The company uses target selection, drug profiling, and clinical and regulatory execution to build a pipeline of anticancer targeted-therapy drugs. Its product pipeline consists of NXP800 and NXP900. The firm's lead product candidate, NXP800 is a clinical-stage, oral small-molecule inhibitor of the Heat Shock Factor 1 (HSF1) pathway. The company targets ovarian clear cell carcinoma (OCCC) and endometrioid ovarian cancer. NXP800 uses a synthetic lethality strategy to reduce the protective factors in the cell that are modified by overactivation of HSP1, with ARID1a gene defective cells being vulnerable. NXP900 is an oral small molecule designed to inhibit the roto-oncogene tyrosine-protein kinase (SRC) and YES1 kinases. The company is used for the treatment of SRC-associated solid tumors.

NVCT Intrinsic Value
HIDDEN
Show
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-27.8m
/
Revenue
0
What is the Net Margin of Nuvectis Pharma Inc?

Based on Nuvectis Pharma Inc's most recent financial statements, the company has Net Margin of 0%.

Back to Top